Comparing Lucentis vs Ozurdex
Lucentis (ranibizumab) | Ozurdex (dexamethasone) |
|
---|
Lucentis (ranibizumab) | Ozurdex (dexamethasone) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Macular Edema Following Retinal Vein Occlusion, Macular Degeneration, Myopic Choroidal Neovascularization, Macular Edema, Diabetic Macular Edema, Diabetic Retinopathy. Lucentis may... View more |
Prescription only
Prescribed for Uveitis, Diabetic Macular Edema, Macular Edema, Uveitis - Posterior. Ozurdex may also be used for purposes not listed in this medication guide. |
Related suggestions Diabetic Macular Edema
Macular Edema
Popular comparisons
|
|||||||||||||||
More about Lucentis (ranibizumab) | More about Ozurdex (dexamethasone) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Lucentis has an average rating of 6.1 out of 10 from a total of 15 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 27% reported a negative effect. |
Ozurdex has an average rating of 6.1 out of 10 from a total of 8 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 38% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Lucentis side effects |
View all Ozurdex side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lucentis prices |
View all Ozurdex prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other ranibizumab brands include: Byooviz, Cimerli, Susvimo | Other dexamethasone brands include: AK-Dex, Decadron Ocumeter, Decadron Phosphate, Ophthalmic, Dexasol, Dextenza, Dexycu, Maxidex | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
216 hours |
N/A |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 1 drugs are known to interact with Lucentis:
|
A total of 89 drugs are known to interact with Ozurdex:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
June 17, 2009 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
|||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.